glp-1 nausea class action in michigan Opinion | Experimentation Is Everywhere, and Science Can't Keep Up glp-1 gi obstruction class action

Jolanda van Hal November in review: GLP-1 breakthroughs, UPFs under fire, Novonesis advances healthy longevity Jolanda van Hal Key takeaways GLP-1 science, product pipelines, and consumer acceptance reached a pivotal point in November, reshaping nutrition, pharma, and metabolic health

A report from Jefferies highlighted that while a healthier population is likely to reduce insurance premiums, this would only be seen in new business

Enteroendocrine cells (EEC) comprise approximately 1% of the intestinal epithelium, but secrete more than 30 different peptide hormones, which makes them the largest endocrine system in the whole body (Worthington 2015)

Most manufacturer savings programs, like NovoCare for Wegovy or LillyDirect for Zepbound, exclude patients with government insurance, including Medicare and Medicaid